|
1
|
Villanueva A, Minguez B, Forner A, Reig M
and Llovet JM: Hepatocellular carcinoma: Novel molecular approaches
for diagnosis, prognosis, and therapy. Annu Rev Med. 61:317–328.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huynh H: Molecularly targeted therapy in
hepatocellular carcinoma. Biochem Pharmacol. 80:550–560. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fisher D, Krasinska L, Coudreuse D and
Novák B: Phosphorylation network dynamics in the control of cell
cycle transitions. J Cell Sci. 125:4703–4711. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nurse P: A long twentieth century of the
cell cycle and beyond. Cell. 100:71–78. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martin SJ, McGahon AJ, Nishioka WK, LaFace
D, Guo X, Th’ng J, Bradbury EM and Green DR: p34cdc2 and apoptosis.
Science. 269:106–107. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laoukili J, Stahl M and Medema RH: FoxM1:
At the crossroads of ageing and cancer. Biochim Biophys Acta.
1775:92–102. 2007.
|
|
7
|
Koo CY, Muir KW and Lam EW: FOXM1: From
cancer initiation to progression and treatment. Biochim Biophys
Acta. 1819:28–37. 2012. View Article : Google Scholar
|
|
8
|
Ye H, Kelly TF, Samadani U, Lim L, Rubio
S, Overdier DG, Roebuck KA and Costa RH: Hepatocyte nuclear factor
3/fork head homolog 11 is expressed in proliferating epithelial and
mesenchymal cells of embryonic and adult tissues. Mol Cell Biol.
17:1626–1641. 1997.PubMed/NCBI
|
|
9
|
Wang IC, Chen YJ, Hughes D, Petrovic V,
Major ML, Park HJ, Tan Y, Ackerson T and Costa RH: Forkhead box M1
regulates the transcriptional network of genes essential for
mitotic progression and genes encoding the SCF (Skp2-Cks1)
ubiquitin ligase. Mol Cell Biol. 25:10875–10894. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Costa RH: FoxM1 dances with mitosis. Nat
Cell Biol. 7:108–110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagata A, Igarashi M, Jinno S, Suto K and
Okayama H: An additional homolog of the fission yeast
cdc25+ gene occurs in humans and is highly expressed in
some cancer cells. New Biol. 3:959–968. 1991.PubMed/NCBI
|
|
12
|
Galaktionov K and Beach D: Specific
activation of cdc25 tyrosine phosphatases by B-type cyclins:
Evidence for multiple roles of mitotic cyclins. Cell. 67:1181–1194.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Molinari M, Mercurio C, Dominguez J,
Goubin F and Draetta GF: Human Cdc25 A inactivation in response to
S phase inhibition and its role in preventing premature mitosis.
EMBO Rep. 1:71–79. 2000. View Article : Google Scholar
|
|
14
|
Karlsson C, Katich S, Hagting A, Hoffmann
I and Pines J: Cdc25B and Cdc25C differ markedly in their
properties as initiators of mitosis. J Cell Biol. 146:573–584.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De Souza CP, Ellem KA and Gabrielli BG:
Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes
nuclear mitotic events. Exp Cell Res. 257:11–21. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoffmann I, Clarke PR, Marcote MJ,
Karsenti E and Draetta G: Phosphorylation and activation of human
cdc25-C by cdc2-cyclin B and its involvement in the
self-amplification of MPF at mitosis. EMBO J. 12:53–63.
1993.PubMed/NCBI
|
|
17
|
Perdiguero E and Nebreda AR: Regulation of
Cdc25C activity during the meiotic G2/M transition. Cell Cycle.
3:733–737. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reyes-Turcu FE, Ventii KH and Wilkinson
KD: Regulation and cellular roles of ubiquitin-specific
deubiquitinating enzymes. Annu Rev Biochem. 78:363–397. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van Leuken RJ, Luna-Vargas MP, Sixma TK,
Wolthuis RM and Medema RH: Usp39 is essential for mitotic spindle
checkpoint integrity and controls mRNA-levels of aurora B. Cell
Cycle. 7:2710–2719. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ríos Y, Melmed S, Lin S and Liu NA:
Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and
pituitary lineage expansion. PLoS Genet. 7:e10012712011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Ji X, Liu X, Yao R, Chi J, Liu S,
Wang Y, Cao W and Zhou Q: Lentivirus-mediated inhibition of USP39
suppresses the growth of breast cancer cells in vitro. Oncol Rep.
30:2871–2877. 2013.PubMed/NCBI
|
|
22
|
Sun XT, Yuan XW, Zhu HT, Deng ZM, Yu DC,
Zhou X and Ding YT: Endothelial precursor cells promote
angiogenesis in hepatocellular carcinoma. World J Gastroenterol.
18:4925–4933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Makarova OV, Makarov EM and Lührmann R:
The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP
are essential for the assembly of mature spliceosomes. EMBO J.
20:2553–2563. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lapenna S and Giordano A: Cell cycle
kinases as therapeutic targets for cancer. Nat Rev Drug Discov.
8:547–566. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smits VA, Klompmaker R, Vallenius T,
Rijksen G, Mäkela TP and Medema RH: p21 inhibits Thr161
phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J
Biol Chem. 275:30638–30643. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guadagno TM and Newport JW: Cdk2 kinase is
required for entry into mitosis as a positive regulator of
Cdc2-cyclin B kinase activity. Cell. 84:73–82. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Atherton-Fessler S, Liu F, Gabrielli B,
Lee MS, Peng CY and Piwnica-Worms H: Cell cycle regulation of the
p34cdc2 inhibitory kinases. Mol Biol Cell. 5:989–1001. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Norbury C, Blow J and Nurse P: Regulatory
phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO
J. 10:3321–3329. 1991.PubMed/NCBI
|
|
30
|
McGowan CH and Russell P: Human Wee1
kinase inhibits cell division by phosphorylating p34cdc2
exclusively on Tyr15. EMBO J. 12:75–85. 1993.PubMed/NCBI
|
|
31
|
Wells NJ, Watanabe N, Tokusumi T, Jiang W,
Verdecia MA and Hunter T: The C-terminal domain of the Cdc2
inhibitory kinase Myt1 interacts with Cdc2 complexes and is
required for inhibition of G(2)/M progression. J Cell Sci.
112:3361–3371. 1999.PubMed/NCBI
|
|
32
|
Cogswell JP, Brown CE, Bisi JE and Neill
SD: Dominant-negative polo-like kinase 1 induces mitotic
catastrophe independent of cdc25C function. Cell Growth Differ.
11:615–623. 2000.
|
|
33
|
Dibb M, Han N, Choudhury J, Hayes S,
Valentine H, West C, Ang YS and Sharrocks AD: The FOXM1-PLK1 axis
is commonly upregulated in oesophageal adenocarcinoma. Br J Cancer.
107:1766–1775. 2012. View Article : Google Scholar : PubMed/NCBI
|
